A detailed history of Exodus Point Capital Management, LP transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 49,945 shares of FDMT stock, worth $408,550. This represents 0.01% of its overall portfolio holdings.

Number of Shares
49,945
Holding current value
$408,550
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$20.93 - $30.01 $1.05 Million - $1.5 Million
49,945 New
49,945 $1.05 Million
Q3 2023

Nov 09, 2023

BUY
$12.64 - $19.76 $370,440 - $579,106
29,307 New
29,307 $373,000
Q1 2021

May 17, 2021

SELL
$35.94 - $52.67 $1.19 Million - $1.75 Million
-33,152 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$38.43 - $47.36 $1.27 Million - $1.57 Million
33,152 New
33,152 $1.37 Million

Others Institutions Holding FDMT

About 4D Molecular Therapeutics, Inc.


  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $265M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.